highlighting the value of pharmacists' interventions

December 1999

A flurry of new studies in big-time medical journals is now highlighting the value of pharmacists' interventions.

They show that pharmacists improve outcomes and reduce costs.

For years pharmacists have said they provide cost-effective improvements to health care.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

highlighting the value of pharmacists' interventions
whether patients on SSRIs can use one of the "triptans" for migraines
Comtan (entacapone), a new drug for advanced Parkinson's disease
Diabetes many patients with type 1 diabetes don't realize when their blood sugar is too low to drive safely
Women's Health estrogen replacement therapy reduces the risk of colorectal cancer
Women's Health PremesisRx, a new prescription product for morning sickness
Ophthalmology more people taking lutein
Infectious Diseases two new flu drugs, Tamiflu (oseltamivir) and Relenza (zanamivir)
Infectious Diseases Do all the new antibacterial soaps, lotions, and gels really help prevent colds and flu
Rheumatoid Arthritis Enbrel (etanercept) or Remicade (infliximab) for rheumatoid arthritis
natural products for the cold and flu season
Cardiology low-molecular-weight heparins
Cardiology amiodarone (Cordarone IV) to help resuscitate cardiac arrest victims
Lots of people are using magnets
Practice taking their quinolone antibiotic, Raxar (grepafloxacin) off the market